nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—Ezetimibe—atherosclerosis	0.115	0.152	CbGbCtD
Ergonovine—ABCB1—Simvastatin—atherosclerosis	0.107	0.141	CbGbCtD
Ergonovine—ABCB1—Pravastatin—atherosclerosis	0.105	0.138	CbGbCtD
Ergonovine—ABCB1—Lovastatin—atherosclerosis	0.105	0.138	CbGbCtD
Ergonovine—CYP3A4—Ezetimibe—atherosclerosis	0.0692	0.0909	CbGbCtD
Ergonovine—CYP3A4—Rosuvastatin—atherosclerosis	0.0692	0.0909	CbGbCtD
Ergonovine—CYP3A4—Simvastatin—atherosclerosis	0.0643	0.0845	CbGbCtD
Ergonovine—CYP3A4—Pravastatin—atherosclerosis	0.0629	0.0827	CbGbCtD
Ergonovine—CYP3A4—Lovastatin—atherosclerosis	0.0629	0.0827	CbGbCtD
Ergonovine—Drug interaction—Rosuvastatin—atherosclerosis	0.00523	0.0483	CcSEcCtD
Ergonovine—Drug interaction—Ezetimibe—atherosclerosis	0.00435	0.0401	CcSEcCtD
Ergonovine—Drug interaction—Simvastatin—atherosclerosis	0.00415	0.0383	CcSEcCtD
Ergonovine—Drug interaction—Pravastatin—atherosclerosis	0.00375	0.0346	CcSEcCtD
Ergonovine—Cramps of lower extremities—Niacin—atherosclerosis	0.00325	0.0299	CcSEcCtD
Ergonovine—Haematuria—Rosuvastatin—atherosclerosis	0.00259	0.0239	CcSEcCtD
Ergonovine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00192	0.0177	CcSEcCtD
Ergonovine—Myocardial infarction—Pravastatin—atherosclerosis	0.00191	0.0176	CcSEcCtD
Ergonovine—Sweating—Niacin—atherosclerosis	0.00189	0.0175	CcSEcCtD
Ergonovine—Muscle spasms—Lovastatin—atherosclerosis	0.00173	0.0159	CcSEcCtD
Ergonovine—Muscle spasms—Ezetimibe—atherosclerosis	0.0017	0.0156	CcSEcCtD
Ergonovine—Tinnitus—Niacin—atherosclerosis	0.00165	0.0153	CcSEcCtD
Ergonovine—Tinnitus—Pravastatin—atherosclerosis	0.00163	0.015	CcSEcCtD
Ergonovine—Muscle spasms—Simvastatin—atherosclerosis	0.00162	0.0149	CcSEcCtD
Ergonovine—Vertigo—Lovastatin—atherosclerosis	0.00162	0.0149	CcSEcCtD
Ergonovine—Palpitations—Ezetimibe—atherosclerosis	0.00156	0.0144	CcSEcCtD
Ergonovine—Chest pain—Lovastatin—atherosclerosis	0.00153	0.0141	CcSEcCtD
Ergonovine—Hypertension—Ezetimibe—atherosclerosis	0.00152	0.014	CcSEcCtD
Ergonovine—Vertigo—Simvastatin—atherosclerosis	0.00151	0.0139	CcSEcCtD
Ergonovine—Chest pain—Ezetimibe—atherosclerosis	0.0015	0.0138	CcSEcCtD
Ergonovine—Muscle spasms—Niacin—atherosclerosis	0.00148	0.0137	CcSEcCtD
Ergonovine—Muscle spasms—Pravastatin—atherosclerosis	0.00146	0.0135	CcSEcCtD
Ergonovine—Chest pain—Simvastatin—atherosclerosis	0.00143	0.0132	CcSEcCtD
Ergonovine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00142	0.0131	CcSEcCtD
Ergonovine—Vertigo—Niacin—atherosclerosis	0.00139	0.0128	CcSEcCtD
Ergonovine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00137	0.0126	CcSEcCtD
Ergonovine—Vertigo—Pravastatin—atherosclerosis	0.00137	0.0126	CcSEcCtD
Ergonovine—Palpitations—Niacin—atherosclerosis	0.00136	0.0126	CcSEcCtD
Ergonovine—Hypertension—Pravastatin—atherosclerosis	0.00131	0.0121	CcSEcCtD
Ergonovine—Dyspnoea—Lovastatin—atherosclerosis	0.00131	0.0121	CcSEcCtD
Ergonovine—Chest pain—Pravastatin—atherosclerosis	0.00129	0.0119	CcSEcCtD
Ergonovine—Dyspnoea—Ezetimibe—atherosclerosis	0.00128	0.0118	CcSEcCtD
Ergonovine—Shock—Niacin—atherosclerosis	0.00124	0.0114	CcSEcCtD
Ergonovine—Dyspnoea—Simvastatin—atherosclerosis	0.00122	0.0113	CcSEcCtD
Ergonovine—Hyperhidrosis—Niacin—atherosclerosis	0.00122	0.0112	CcSEcCtD
Ergonovine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0012	0.0111	CcSEcCtD
Ergonovine—Hyperhidrosis—Pravastatin—atherosclerosis	0.0012	0.0111	CcSEcCtD
Ergonovine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00118	0.0109	CcSEcCtD
Ergonovine—Hypotension—Niacin—atherosclerosis	0.00118	0.0109	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00118	0.0109	CcSEcCtD
Ergonovine—Abdominal pain—Lovastatin—atherosclerosis	0.00116	0.0107	CcSEcCtD
Ergonovine—Dizziness—Rosuvastatin—atherosclerosis	0.00115	0.0106	CcSEcCtD
Ergonovine—Abdominal pain—Ezetimibe—atherosclerosis	0.00114	0.0105	CcSEcCtD
Ergonovine—Dyspnoea—Niacin—atherosclerosis	0.00112	0.0104	CcSEcCtD
Ergonovine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00112	0.0104	CcSEcCtD
Ergonovine—Dyspnoea—Pravastatin—atherosclerosis	0.00111	0.0102	CcSEcCtD
Ergonovine—Abdominal pain—Simvastatin—atherosclerosis	0.00109	0.01	CcSEcCtD
Ergonovine—Headache—Rosuvastatin—atherosclerosis	0.00108	0.01	CcSEcCtD
Ergonovine—Gastrointestinal pain—Niacin—atherosclerosis	0.00103	0.00951	CcSEcCtD
Ergonovine—Nausea—Rosuvastatin—atherosclerosis	0.00103	0.00949	CcSEcCtD
Ergonovine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00101	0.00936	CcSEcCtD
Ergonovine—Diarrhoea—Lovastatin—atherosclerosis	0.001	0.00926	CcSEcCtD
Ergonovine—Abdominal pain—Niacin—atherosclerosis	0.000996	0.00919	CcSEcCtD
Ergonovine—Diarrhoea—Ezetimibe—atherosclerosis	0.000985	0.00908	CcSEcCtD
Ergonovine—Abdominal pain—Pravastatin—atherosclerosis	0.000981	0.00905	CcSEcCtD
Ergonovine—Dizziness—Lovastatin—atherosclerosis	0.000971	0.00895	CcSEcCtD
Ergonovine—Dizziness—Ezetimibe—atherosclerosis	0.000952	0.00878	CcSEcCtD
Ergonovine—Diarrhoea—Simvastatin—atherosclerosis	0.000939	0.00866	CcSEcCtD
Ergonovine—Vomiting—Lovastatin—atherosclerosis	0.000933	0.00861	CcSEcCtD
Ergonovine—Headache—Lovastatin—atherosclerosis	0.000919	0.00848	CcSEcCtD
Ergonovine—Vomiting—Ezetimibe—atherosclerosis	0.000915	0.00844	CcSEcCtD
Ergonovine—Dizziness—Simvastatin—atherosclerosis	0.000908	0.00837	CcSEcCtD
Ergonovine—Headache—Ezetimibe—atherosclerosis	0.000902	0.00832	CcSEcCtD
Ergonovine—Vomiting—Simvastatin—atherosclerosis	0.000873	0.00805	CcSEcCtD
Ergonovine—Nausea—Lovastatin—atherosclerosis	0.000872	0.00804	CcSEcCtD
Ergonovine—Diarrhoea—Niacin—atherosclerosis	0.000862	0.00795	CcSEcCtD
Ergonovine—Headache—Simvastatin—atherosclerosis	0.00086	0.00793	CcSEcCtD
Ergonovine—Nausea—Ezetimibe—atherosclerosis	0.000855	0.00788	CcSEcCtD
Ergonovine—Diarrhoea—Pravastatin—atherosclerosis	0.000849	0.00783	CcSEcCtD
Ergonovine—Dizziness—Niacin—atherosclerosis	0.000834	0.00769	CcSEcCtD
Ergonovine—Dizziness—Pravastatin—atherosclerosis	0.000821	0.00757	CcSEcCtD
Ergonovine—Nausea—Simvastatin—atherosclerosis	0.000815	0.00752	CcSEcCtD
Ergonovine—Vomiting—Niacin—atherosclerosis	0.000801	0.00739	CcSEcCtD
Ergonovine—Headache—Niacin—atherosclerosis	0.00079	0.00728	CcSEcCtD
Ergonovine—Vomiting—Pravastatin—atherosclerosis	0.000789	0.00728	CcSEcCtD
Ergonovine—Headache—Pravastatin—atherosclerosis	0.000777	0.00717	CcSEcCtD
Ergonovine—Nausea—Niacin—atherosclerosis	0.000749	0.0069	CcSEcCtD
Ergonovine—Nausea—Pravastatin—atherosclerosis	0.000737	0.0068	CcSEcCtD
Ergonovine—HTR1E—Signaling Pathways—APOA1—atherosclerosis	5.19e-05	0.000399	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PRKCG—atherosclerosis	5.19e-05	0.000399	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOA4—atherosclerosis	5.18e-05	0.000398	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VWF—atherosclerosis	5.17e-05	0.000397	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	5.15e-05	0.000396	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOC3—atherosclerosis	5.14e-05	0.000395	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	5.11e-05	0.000393	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LDLR—atherosclerosis	5.1e-05	0.000392	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP7A1—atherosclerosis	5.08e-05	0.000391	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLTP—atherosclerosis	5.04e-05	0.000387	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AGT—atherosclerosis	5.03e-05	0.000386	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ESR1—atherosclerosis	5.02e-05	0.000385	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	5.01e-05	0.000385	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL3—atherosclerosis	4.99e-05	0.000383	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—F2—atherosclerosis	4.96e-05	0.000381	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	4.93e-05	0.000379	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	4.93e-05	0.000379	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	4.92e-05	0.000378	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	4.91e-05	0.000377	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	4.86e-05	0.000373	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.81e-05	0.00037	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NCF1—atherosclerosis	4.77e-05	0.000367	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CG—atherosclerosis	4.74e-05	0.000364	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.74e-05	0.000364	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP27A1—atherosclerosis	4.7e-05	0.000361	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	4.68e-05	0.000359	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—F2—atherosclerosis	4.65e-05	0.000357	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	4.64e-05	0.000357	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	4.61e-05	0.000354	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.6e-05	0.000353	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AGT—atherosclerosis	4.57e-05	0.000351	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—MAPK3—atherosclerosis	4.54e-05	0.000349	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR2—atherosclerosis	4.51e-05	0.000346	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EDNRA—atherosclerosis	4.51e-05	0.000346	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—INS—atherosclerosis	4.49e-05	0.000345	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CYBA—atherosclerosis	4.49e-05	0.000345	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOA2—atherosclerosis	4.45e-05	0.000342	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	4.45e-05	0.000342	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	4.45e-05	0.000342	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALOX15—atherosclerosis	4.45e-05	0.000342	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CG—atherosclerosis	4.45e-05	0.000342	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL2—atherosclerosis	4.42e-05	0.000339	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	4.41e-05	0.000339	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ABCG5—atherosclerosis	4.4e-05	0.000338	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PLAT—atherosclerosis	4.39e-05	0.000338	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VWF—atherosclerosis	4.39e-05	0.000338	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GHRL—atherosclerosis	4.39e-05	0.000338	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PARP1—atherosclerosis	4.39e-05	0.000338	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.37e-05	0.000336	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.37e-05	0.000336	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	4.37e-05	0.000336	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IGF1—atherosclerosis	4.34e-05	0.000334	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	4.34e-05	0.000333	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.3e-05	0.00033	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	4.28e-05	0.000329	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LPA—atherosclerosis	4.25e-05	0.000327	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	4.24e-05	0.000326	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—F2—atherosclerosis	4.22e-05	0.000324	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SERPINE1—atherosclerosis	4.12e-05	0.000317	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—BGN—atherosclerosis	4.12e-05	0.000316	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOA5—atherosclerosis	4.07e-05	0.000313	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	4.06e-05	0.000312	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CG—atherosclerosis	4.04e-05	0.00031	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	3.95e-05	0.000304	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NOS3—atherosclerosis	3.94e-05	0.000302	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.92e-05	0.000301	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.89e-05	0.000299	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	3.88e-05	0.000298	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KNG1—atherosclerosis	3.86e-05	0.000296	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AGTR1—atherosclerosis	3.83e-05	0.000295	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	3.83e-05	0.000295	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	3.83e-05	0.000295	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	3.82e-05	0.000293	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALOX5—atherosclerosis	3.79e-05	0.000291	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	3.78e-05	0.000291	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL2—atherosclerosis	3.76e-05	0.000289	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	3.74e-05	0.000287	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	3.74e-05	0.000287	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	3.74e-05	0.000287	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PLG—atherosclerosis	3.74e-05	0.000287	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.64e-05	0.00028	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—F2—atherosclerosis	3.59e-05	0.000276	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SOCS3—atherosclerosis	3.54e-05	0.000272	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL8—atherosclerosis	3.49e-05	0.000268	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.45e-05	0.000265	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	3.43e-05	0.000264	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP3—atherosclerosis	3.42e-05	0.000263	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF2—atherosclerosis	3.4e-05	0.000261	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NAMPT—atherosclerosis	3.4e-05	0.000261	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LIPC—atherosclerosis	3.38e-05	0.000259	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—AKT1—atherosclerosis	3.37e-05	0.000259	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOC3—atherosclerosis	3.36e-05	0.000258	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LDLR—atherosclerosis	3.33e-05	0.000256	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—atherosclerosis	3.32e-05	0.000255	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOB—atherosclerosis	3.3e-05	0.000254	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	3.28e-05	0.000252	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL8—atherosclerosis	3.27e-05	0.000252	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	3.26e-05	0.00025	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CETP—atherosclerosis	3.26e-05	0.00025	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EDN1—atherosclerosis	3.25e-05	0.00025	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LCAT—atherosclerosis	3.25e-05	0.00025	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—FABP4—atherosclerosis	3.25e-05	0.00025	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL5—atherosclerosis	3.23e-05	0.000248	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.2e-05	0.000246	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	3.2e-05	0.000246	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA4—atherosclerosis	3.19e-05	0.000245	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PLG—atherosclerosis	3.18e-05	0.000244	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MMP9—atherosclerosis	3.16e-05	0.000243	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LPL—atherosclerosis	3.15e-05	0.000242	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.13e-05	0.000241	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NFKB1—atherosclerosis	3.12e-05	0.00024	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SCARB1—atherosclerosis	3.12e-05	0.00024	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK8—atherosclerosis	3.07e-05	0.000236	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	3.07e-05	0.000236	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT1—atherosclerosis	3.06e-05	0.000235	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	3.01e-05	0.000231	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SPP1—atherosclerosis	2.99e-05	0.00023	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	2.97e-05	0.000228	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMGCR—atherosclerosis	2.95e-05	0.000226	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	2.91e-05	0.000223	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.9e-05	0.000222	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	2.89e-05	0.000222	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.89e-05	0.000222	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—atherosclerosis	2.84e-05	0.000218	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—atherosclerosis	2.81e-05	0.000216	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOB—atherosclerosis	2.81e-05	0.000216	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	2.78e-05	0.000214	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	2.76e-05	0.000212	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	2.76e-05	0.000212	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.74e-05	0.000211	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.74e-05	0.000211	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA2—atherosclerosis	2.74e-05	0.000211	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.74e-05	0.000211	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	2.74e-05	0.000211	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.71e-05	0.000208	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AGT—atherosclerosis	2.7e-05	0.000207	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK3—atherosclerosis	2.68e-05	0.000206	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	2.68e-05	0.000206	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOE—atherosclerosis	2.64e-05	0.000203	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—atherosclerosis	2.64e-05	0.000203	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ABCA1—atherosclerosis	2.63e-05	0.000202	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CAV1—atherosclerosis	2.62e-05	0.000201	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPA—atherosclerosis	2.62e-05	0.000201	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOA1—atherosclerosis	2.61e-05	0.000201	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	2.61e-05	0.0002	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—atherosclerosis	2.6e-05	0.0002	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	2.54e-05	0.000195	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—BGN—atherosclerosis	2.54e-05	0.000195	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	2.53e-05	0.000194	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ESR1—atherosclerosis	2.52e-05	0.000194	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA5—atherosclerosis	2.51e-05	0.000193	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—F2—atherosclerosis	2.49e-05	0.000192	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.42e-05	0.000186	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	2.39e-05	0.000183	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	2.35e-05	0.000181	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.33e-05	0.000179	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	2.29e-05	0.000176	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	2.28e-05	0.000176	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—INS—atherosclerosis	2.26e-05	0.000174	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMOX1—atherosclerosis	2.25e-05	0.000173	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	2.25e-05	0.000173	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	2.25e-05	0.000173	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	2.23e-05	0.000171	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL2—atherosclerosis	2.22e-05	0.000171	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	2.22e-05	0.000171	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IGF1—atherosclerosis	2.18e-05	0.000168	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOB—atherosclerosis	2.16e-05	0.000166	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	2.15e-05	0.000165	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—F2—atherosclerosis	2.12e-05	0.000163	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTM1—atherosclerosis	2.1e-05	0.000161	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.09e-05	0.000161	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LIPC—atherosclerosis	2.08e-05	0.00016	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	2.07e-05	0.000159	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOC3—atherosclerosis	2.07e-05	0.000159	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—LPL—atherosclerosis	2.06e-05	0.000158	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LDLR—atherosclerosis	2.05e-05	0.000158	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	2.03e-05	0.000156	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPX1—atherosclerosis	2.01e-05	0.000154	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CETP—atherosclerosis	2.01e-05	0.000154	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOS3—atherosclerosis	1.98e-05	0.000152	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—atherosclerosis	1.96e-05	0.000151	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CD36—atherosclerosis	1.96e-05	0.00015	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	1.94e-05	0.000149	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.92e-05	0.000148	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—INS—atherosclerosis	1.92e-05	0.000148	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	1.89e-05	0.000145	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	1.86e-05	0.000143	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—atherosclerosis	1.86e-05	0.000143	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARA—atherosclerosis	1.82e-05	0.00014	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.81e-05	0.000139	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—atherosclerosis	1.81e-05	0.000139	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	1.76e-05	0.000136	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AGT—atherosclerosis	1.76e-05	0.000135	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	1.76e-05	0.000135	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOE—atherosclerosis	1.73e-05	0.000133	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CAV1—atherosclerosis	1.71e-05	0.000131	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOA1—atherosclerosis	1.71e-05	0.000131	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	1.7e-05	0.00013	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	1.68e-05	0.000129	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	1.67e-05	0.000128	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.62e-05	0.000124	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	1.59e-05	0.000122	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	1.57e-05	0.000121	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.56e-05	0.00012	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	1.55e-05	0.000119	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	1.54e-05	0.000118	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PPARG—atherosclerosis	1.5e-05	0.000116	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.49e-05	0.000115	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—INS—atherosclerosis	1.48e-05	0.000113	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.44e-05	0.000111	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	1.43e-05	0.00011	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.42e-05	0.000109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	1.41e-05	0.000109	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.39e-05	0.000107	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—atherosclerosis	1.35e-05	0.000104	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.35e-05	0.000104	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	1.35e-05	0.000104	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.34e-05	0.000103	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOB—atherosclerosis	1.33e-05	0.000102	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.31e-05	0.000101	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.31e-05	0.000101	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	1.31e-05	0.000101	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NOS3—atherosclerosis	1.29e-05	9.94e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.29e-05	9.94e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—LPL—atherosclerosis	1.27e-05	9.75e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPX1—atherosclerosis	1.24e-05	9.52e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.21e-05	9.32e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CD36—atherosclerosis	1.21e-05	9.27e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.2e-05	9.23e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTGS2—atherosclerosis	1.18e-05	9.09e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.15e-05	8.82e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.14e-05	8.78e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.12e-05	8.62e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.11e-05	8.56e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AGT—atherosclerosis	1.09e-05	8.34e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOE—atherosclerosis	1.06e-05	8.18e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.05e-05	8.1e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.05e-05	8.08e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—atherosclerosis	9.87e-06	7.58e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	9.6e-06	7.38e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PPARG—atherosclerosis	9.27e-06	7.12e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	9.1e-06	6.99e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—INS—atherosclerosis	9.09e-06	6.98e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	8.39e-06	6.45e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—atherosclerosis	8.33e-06	6.4e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NOS3—atherosclerosis	7.97e-06	6.13e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	7.74e-06	5.95e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTGS2—atherosclerosis	7.29e-06	5.6e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—atherosclerosis	5.95e-06	4.57e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—atherosclerosis	3.66e-06	2.82e-05	CbGpPWpGaD
